Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from LBT Innovations Limited ( (AU:CC5) ) is now available.
Clever Culture Systems Ltd has issued 2,500,000 fully paid ordinary shares without a prospectus under the Corporations Act, and has confirmed it remains compliant with its financial reporting and continuous disclosure obligations, with no excluded information requiring disclosure. The cleansing notice supports secondary trading of the new shares, signalling continued regulatory compliance and providing transparency for investors following the equity issuance.
More about LBT Innovations Limited
Clever Culture Systems Ltd is an Adelaide-based provider of intelligent automation solutions for microbiology laboratories. Its flagship product, the APAS Independence, uses artificial intelligence and machine learning to automate the imaging, analysis and interpretation of microbiology culture plates, and is currently the only US FDA-cleared AI technology for automated culture plate reading. The system is sold to pharmaceutical manufacturing laboratories for environmental monitoring and to clinical laboratories as an in vitro diagnostic for infectious diseases, with Thermo Fisher Scientific acting as exclusive distributor to clinical customers in the US and selected European markets.
Average Trading Volume: 1,607,881
Technical Sentiment Signal: Hold
Current Market Cap: A$60.77M
See more insights into CC5 stock on TipRanks’ Stock Analysis page.